Immunologic basis for revaccination of HIV-infected children receiving HAART

Author： Rainwater-Lovett Kaitlin   Moss William J  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.1, 2011-01, pp. : 59-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Evaluation of Glucose Homeostasis in a Cohort of HAART-Treated HIV-Infected Children: A Longitudinal, Observational Cohort Study

By Viganò Alessandra  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 101-109

Adis International

Access to resources Recommend Favorite

Metabolic complications of antiretroviral therapy in HIV-infected children

By Eley Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 37-49

Informa Healthcare

Access to resources Recommend Favorite

Varicella Zoster Infection in HIV-Infected Children

By Rongkavilit C.  

Pediatric Drugs, Vol. 2, Iss. 4, 2000-07 ,pp. : 291-297

Adis International

Access to resources Recommend Favorite

Switch to efavirenz improves lipid profile in HIV-infected children

By  

Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Immunogenicity and Tolerability of a Trivalent Virosomal Influenza Vaccine in a Cohort of HIV-infected Children

By Zuccotti GV   Zenga A   Durando P   Massone L   Bruzzone B   Sala D   Riva E  

The Journal of International Medical Research, Vol. 32, Iss. 5, 2004-09 ,pp. : 492-499

Field House Publishing

Access to resources Recommend Favorite